ENDPOINTS

Endo and Mallinckrodt to merge in $6.7B deal

The rumors are true: Endo will combine with Mallinckrodt in a deal worth $6.7 billion. Endo will become a wholly-owned subsidiary of Mallinckrodt, the companies said Thursday. Mallinckrodt ...

Mar 13, 2025 - 12:14
 0
Endo and Mallinckrodt to merge in $6.7B deal
The rumors are true: Endo will combine with Mallinckrodt in a deal worth $6.7 billion. Endo will become a wholly-owned subsidiary of Mallinckrodt, the companies said Thursday. Mallinckrodt ...
Read More

Tags:

Previous Article

Daily briefing: Saturn has 128 new moons

Next Article

Amgen reports more Phase 3 Uplizna data in myasthenia gravis ahead of FDA filing

Related Posts

AstraZeneca cuts UK funding pledge; Viking says it has ‘enough’ API for trials

AstraZeneca cuts UK funding pledge; Viking says it has ...

Feb 9, 2025  0

BioNTech vets raise about $90M in Series A for bispecific immunology research

BioNTech vets raise about $90M in Series A for bispecif...

Feb 14, 2025  0

Bayer cautions pharma sales dip this year despite major upcoming launches

Bayer cautions pharma sales dip this year despite major...

Mar 5, 2025  0